Cervical Cancer - Oncology Based Molecular Diagnostics Market Statistics
The global cervical cancer oncology based molecular diagnostics market size was valued at US$ 444.7 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 5% from 2024 to 2030.